prognostic marker

Related by string. * Prognostic . prognostics . Prognostics : unfavorable prognostic . prognostic significance . prognostic markers . prognostic indicator . prognostic indicators . prognostic factors / marked . marking . marks . Marks . MARK . Marking : By MARK LONG . spokesman Mark Regev . Mark Zandi chief . mile marker . keeper Mark Schwarzer . mark * independent prognostic marker *

Related by context. Frequent words. (Click for all words.) 74 prognostic factor 69 biomarker 69 immunohistochemical 68 susceptibility gene 68 genetic polymorphisms 67 surrogate marker 66 microRNA expression 65 clusterin 65 FLT3 65 prognostic 65 osteopontin 65 IGF 1R 65 FDG PET 64 Stat5 64 BRAF mutation 64 galectin 3 63 biomarkers 63 PCa 63 histone modifications 63 Notch signaling 63 tumorigenesis 63 mRNA expression 63 K ras 63 KRAS mutations 63 breast carcinoma 63 tumor suppressor gene 63 Lp PLA2 62 TLR3 62 malignant transformation 62 pheochromocytoma 62 potent inhibitor 62 oncogenic 62 induces apoptosis 62 iNOS 62 EGFr 62 progesterone receptor 62 NGAL 62 neoplastic 61 distant metastasis 61 downregulation 61 Prognostic 61 xenograft models 61 EGFR inhibitors 61 myeloproliferative disorders 61 autoantibody 61 platelet activation 61 K RAS 61 estrogen receptor ER 61 induce apoptosis 61 cystatin C 61 anti fibrotic 61 vascular inflammation 61 EGFR mutation 61 tumor angiogenesis 61 risk stratification 61 evolutionarily conserved 61 serotonin receptor 61 cardiac dysfunction 61 imaging modality 61 isoform 61 Metastatic 61 poorer prognosis 61 TNF α 60 histopathological 60 IGFBP 3 60 JAK2 60 estrogen receptor beta 60 PlGF 60 antiangiogenic 60 single nucleotide polymorphism 60 hepatocellular carcinoma 60 CYP#C# [001] 60 liver fibrosis 60 aetiology 60 cholangiocarcinoma 60 Methylation 60 Aurora kinase 60 neoplasm 60 EphA2 60 lung fibrosis 60 protein kinase C 60 chemopreventive 60 lymph node metastases 60 metastatic cancers 60 mesothelin 60 autoantibodies 60 fulvestrant 60 atherosclerotic disease 60 pertuzumab 60 tumor antigen 59 EGFR mutations 59 Lenalidomide 59 antitumor 59 Imatinib 59 receptor antagonists 59 pro apoptotic 59 subtype 59 phosphatases 59 enzymatic activity 59 protein misfolding 59 stratify patients

Back to home page